RE: How do you23 Apr 2020 23:42
The deal with AZN for COPD, which was to help develop and trial the drug was for 230 million plus royalties. So now we are coming to the table with the finished article, having ‘gone it alone’, and COVID has turned up. I don’t have the knowledge to put a price on it, but it’s got to be orders of magnitude more than that previous deal.